ReviewJournal of thrombosis and thrombolysis2018

Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy.

Michelangelo Sartori et al.PubMed ↗Publisher ↗

No numbers read from the abstract.